Jazz Pharmaceuticals plc buy Morgan Stanley
Start price
12.12.24
/
50%
€120.35
Target price
12.12.25
€167.02
Performance (%)
-10.30%
Price
28.08.25
€107.95
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.30%. This prediction currently runs until 12.12.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 3.898% | 3.898% |
iShares Core DAX® | -0.930% | 0.363% |
iShares Nasdaq 100 | 1.767% | 0.797% |
iShares Nikkei 225® | 1.666% | 6.221% |
iShares S&P 500 | 1.416% | 1.109% |
Comments by Morgan_Stanley for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $175.00 price target on the stock, up previously from $140.00.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Morgan_Stanley for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€107.95
28.08.25
28.08.25
-
28.08.26
28.08.26
0.00%
28.08.25
28.08.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€92.16
06.08.25
06.08.25
€140.03
06.08.26
06.08.26
17.13%
28.08.25
28.08.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€99.04
22.07.25
22.07.25
€141.14
22.07.26
22.07.26
9.00%
28.08.25
28.08.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€90.20
07.05.25
07.05.25
€146.33
07.05.26
07.05.26
19.68%
28.08.25
28.08.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€128.00
07.03.25
07.03.25
€168.73
07.03.26
07.03.26
-15.66%
28.08.25
28.08.25